Morgan Stanley on Wednesday lowered the price target for retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 112 Saudi riyals from 120 riyals, while maintaining its overweight rating.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)